First-in-Human – Phase 1/2 refractory PTCL therapy.
A Phase II trial will begin to support registration, once Myeloid establishes the recommended dose.
A Phase II trial will begin to support registration, once Myeloid establishes the recommended dose.
The drug can safely increase platelet levels in patients with immune thrombocytopenia.
The trial will analyse the safety and efficacy of varying doses of sonelokimab versus placebo in more than 200 subjects.
The trial is evaluating its frequency-tuned electromagnetic field treatment in facilitating recovery in individuals with moderately-severe ischemic stroke.
Top CRO Companies - Cohortias continue to grow in South America. We are a local based Clinical Research Organization with one goal: expand clinical research access across Latin American countries.
Best CRO in Latin America - Cohortias continue to grow in South America. We are a local based Clinical Research Organization with one goal: expand clinical research access across Latin American countries.
Clinical Trials South America - Cohortias continue to grow in South America. We are a local based Clinical Research Organization with one goal: expand clinical research access across Latin American countries.
Provide administrative support to clinical projects under direction of line manager and/or other designated clinical team members. Assists with general administrative functions as required.